Clinica BavieraXMAD:CBAV -0.36%99 OCF Yield % is 8.60 as of Jun. 28, 2026, which is 33% below its 10-year median of 12.82. GuruFocus rates XMAD:CBAV with a GF Score™ of 99/100 and a GF Value™ of €41.30 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Clinica Baviera ranks better than 80.37% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Clinica Baviera's OCF Yield % or its related term are showing as below:
XMAD:CBAV'
s OCF Yield % Range Over the Past 10 Years
Min: 1.6 Med: 12.82 Max: 20.86
Current: 8.6
During the past 13 years, the highest OCF Yield % of Clinica Baviera was 20.86%. The lowest was 1.60%. And the median was 12.82%.
XMAD:CBAV's OCF Yield % is ranked better than 80.37% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.045
vs XMAD:CBAV: 8.60
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Clinica Baviera OCF Yield % Related Terms
Clinica Baviera OCF Yield % Historical Data
* Premium members only.
The historical data trend for Clinica Baviera's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:CBAV vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Clinica Baviera's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinica Baviera OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Clinica Baviera's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinica Baviera (XMAD:CBAV) has a OCF Yield % of 8.60 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Clinica Baviera and its competitors. This is 33% below median its historical median of 12.82. Over the past decade, Clinica Baviera's OCF Yield % has ranged from 1.60 to 20.86. According to the industry distribution chart, Clinica Baviera ranks #42 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 19.6%.
Is Clinica Baviera's OCF Yield % too high?
Clinica Baviera's current OCF Yield % of 8.60 is 33% below median its 10-year median of 12.82. Over the past 10 years, this metric has ranged from a low of 1.60 to a high of 20.86. The Medical Diagnostics & Research industry median OCF Yield % is 1.05. Clinica Baviera's value of 8.60 is 723% above this industry median. Based on the distribution chart, Clinica Baviera ranks #42 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Clinica Baviera has a GF Score™ of 99/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinica Baviera ranks #42 out of 214 companies for OCF Yield %. This places Clinica Baviera in the top 20% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.05. Clinica Baviera's value of 8.60 is 723% above this benchmark. Historically, Clinica Baviera's own OCF Yield % has ranged from 1.60 to 20.86 over the past decade. While the company's 10-year median is 12.82 vs. the industry median of 1.05, Clinica Baviera has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.05, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clinica Baviera's current OCF Yield % of 8.60 is 723% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Clinica Baviera and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinica Baviera's current OCF Yield % is 8.60, which is 33% below median its own 10-year median of 12.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.30, compared to a current price of €55.20 — trading 33.7% above its estimated fair value. The current OCF Yield % is 8.60, which is 33% below median its 10-year median of 12.82 and 723% above the Medical Diagnostics & Research industry median of 1.05. Clinica Baviera's overall GF Score™ is 99/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current OCF Yield % is 8.60 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?
Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued.
The current stock price of €55.20 is trading 33.7% above its estimated GF Value™ of €41.30.
GuruFocus considers Clinica Baviera to be Significantly Overvalued.
Key valuation signals for XMAD:CBAV:
OCF Yield %: 8.60 (33% below median its 10-year median of 12.82)
GF Value™: €41.30 vs. price of €55.20 (33.7% above fair value)
Industry Position: 723% above the Medical Diagnostics & Research median (#42 of 214)
No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
99GF Score
Get the complete analysis for XMAD:CBAV
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:CBAV has been successfully added to your 
